David Gaist

Medicin og biovidenskab

1. Aged, 80 and over 28%
2. Anticoagulants 25%
3. Aspirin 31%
4. Azathioprine 13%
5. Case-Control Studies 80%
6. Cerebral Hemorrhage 96%
7. Cohort Studies 20%
8. Confidence Intervals 61%
9. Denmark 100%
10. Dizygotic Twins 11%
11. Drug Utilization 13%
12. Elderly 15%
13. Epilepsy 11%
14. General Practice 16%
15. Glioma 23%
16. Hand Strength 15%
17. Headache 15%
18. Health 19%
19. Hormone Replacement Therapy 11%
20. Hydrochlorothiazide 19%
21. Hydroxymethylglutaryl-CoA Reductase Inhibitors 48%
22. Incidence 22%
23. International Normalized Ratio 12%
24. Logistic Models 12%
25. Migraine Disorders 31%
26. Migraine with Aura 28%
27. Mortality 14%
28. Myasthenia Gravis 21%
29. Nerve Fibers 14%
30. Neural Conduction 18%
31. Odds Ratio 45%
32. Oxaliplatin 17%
33. Peripheral Nerves 16%
34. Pharmaceutical Preparations 25%
35. Platelet Aggregation Inhibitors 16%
36. Polyneuropathies 35%
37. Population 37%
38. Population Control 12%
39. Prescriptions 15%
40. Registries 44%
41. Serotonin Uptake Inhibitors 12%
42. Skin 12%
43. Skin Neoplasms 16%
44. Stroke 79%
45. Subarachnoid Hemorrhage 37%
46. Subdural Hematoma 25%
47. Transient Ischemic Attack 20%
48. Twin Studies 13%
49. Twins 59%
50. Warfarin 12%